Lunit Inc.
Lunit Inc. provides AI-powered software and solutions for cancer diagnostics and therapeutics in South Korea. It offers AI solution for chest X-ray and mammography, as well as AI solution for digital breast tomosynthesis, and AI-powered biomarker for immune phenotyping and PD-L1 biomarker analyzer. The company has a strategic collaboration with AstraZeneca for the development of Lunit SCOPE Genot… Read more
Lunit Inc. (328130) - Net Assets
Latest net assets as of September 2025: ₩164.68 Billion KRW
Based on the latest financial reports, Lunit Inc. (328130) has net assets worth ₩164.68 Billion KRW as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (₩389.25 Billion) and total liabilities (₩224.57 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | ₩164.68 Billion |
| % of Total Assets | 42.31% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 1501.37 |
Lunit Inc. - Net Assets Trend (2019–2024)
This chart illustrates how Lunit Inc.'s net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Lunit Inc. (2019–2024)
The table below shows the annual net assets of Lunit Inc. from 2019 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | ₩164.86 Billion | -29.88% |
| 2023-12-31 | ₩235.11 Billion | +241.19% |
| 2022-12-31 | ₩68.91 Billion | +3281.88% |
| 2021-12-31 | ₩2.04 Billion | +101.56% |
| 2020-12-31 | ₩-130.64 Billion | -121.89% |
| 2019-12-31 | ₩-58.87 Billion | -- |
Equity Component Analysis
This analysis shows how different components contribute to Lunit Inc.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 31663694274000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Other Components | ₩542.69 Billion | 329.18% |
| Total Equity | ₩164.86 Billion | 100.00% |
Lunit Inc. Competitors by Market Cap
The table below lists competitors of Lunit Inc. ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
DeFi Technologies Inc
OTCQB:DEFTF
|
$590.86 Million |
|
Invesco Mortgage Capital Inc
NYSE:IVR
|
$590.88 Million |
|
Chalet Hotels Limited
NSE:CHALET
|
$591.05 Million |
|
Holly Futures Co. Ltd. A
SHE:001236
|
$591.25 Million |
|
Sichuan Jiuyuan Yinhai Software Co Ltd
SHE:002777
|
$590.69 Million |
|
Shiny Chemical Industrial Co Ltd
TW:1773
|
$590.61 Million |
|
CTO Realty Growth Inc
NYSE:CTO
|
$590.56 Million |
|
Devyani International Limited
NSE:DEVYANI
|
$590.49 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Lunit Inc.'s equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 235,109,506,780 to 164,861,091,170, a change of -70,248,415,610 (-29.9%).
- Net loss of 82,420,863,340 reduced equity.
- Share repurchases of 1,466,525,690 reduced equity.
- New share issuances of 1,466,525,690 increased equity.
- Other factors increased equity by 12,172,447,730.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | ₩-82.42 Billion | -49.99% |
| Share Repurchases | ₩1.47 Billion | -0.89% |
| Share Issuances | ₩1.47 Billion | +0.89% |
| Other Changes | ₩12.17 Billion | +7.38% |
| Total Change | ₩- | -29.88% |
Book Value vs Market Value Analysis
This analysis compares Lunit Inc.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 6.74x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2019-12-31 | ₩-5596.52 | ₩38500.00 | x |
| 2020-12-31 | ₩-5992.01 | ₩38500.00 | x |
| 2021-12-31 | ₩93.46 | ₩38500.00 | x |
| 2022-12-31 | ₩2719.27 | ₩38500.00 | x |
| 2023-12-31 | ₩8191.32 | ₩38500.00 | x |
| 2024-12-31 | ₩5709.84 | ₩38500.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Lunit Inc. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -49.99%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -152.13%
- • Asset Turnover: 0.12x
- • Equity Multiplier: 2.64x
- Recent ROE (-49.99%) is above the historical average (-623.03%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2019 | 0.00% | -23675.02% | 0.01x | 0.00x | ₩-41.08 Billion |
| 2020 | 0.00% | -5855.73% | 0.06x | 0.00x | ₩-70.68 Billion |
| 2021 | -3615.79% | -1109.74% | 0.07x | 46.06x | ₩-73.88 Billion |
| 2022 | -56.77% | -282.12% | 0.14x | 1.41x | ₩-46.01 Billion |
| 2023 | -15.65% | -146.72% | 0.09x | 1.14x | ₩-60.31 Billion |
| 2024 | -49.99% | -152.13% | 0.12x | 2.64x | ₩-98.91 Billion |
Industry Comparison
This section compares Lunit Inc.'s net assets metrics with peer companies in the Health Information Services industry.
Industry Context
- Industry: Health Information Services
- Average net assets among peers: $23,783,193,603
- Average return on equity (ROE) among peers: -23.42%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Lunit Inc. (328130) | ₩164.68 Billion | 0.00% | 1.36x | $590.83 Million |
| BIT Computer Co. Ltd (032850) | $66.21 Billion | 8.36% | 0.21x | $42.37 Million |
| ezCaretech Co. LTD (099750) | $34.16 Billion | -28.06% | 0.73x | $8.27 Million |
| SyntekaBio Inc (226330) | $24.94 Billion | -28.92% | 0.75x | $28.61 Million |
| Carelabs Co.Ltd (263700) | $10.40 Billion | 18.59% | 0.52x | $22.17 Million |
| Deep Noid Inc. (315640) | $27.18 Billion | -24.79% | 0.27x | $42.49 Million |
| Vuno Inc. (338220) | $5.42 Billion | -109.11% | 0.38x | $139.34 Million |
| LifeSemantics Corp. (347700) | $-1.84 Billion | 0.00% | 0.00x | $189.97 Million |